Search Results - "Cosgrove, DO"

Preliminary assessment of ShearWave™ elastography features in predicting breast lesion malignancy by Cosgrove, DO, Dorñ, C, Tourasse, C, Ohlinger, R, Madjar, H, Hooley, R, Balu-Maestro, C, Mendelson, E, Svensson, W, Tardivon, A, Cossi, A, Barke, L, Larsen, L

Get full text

Science, Medicine, And The Future: Microbubble Contrast Agents: A New Era In Ultrasound by Blomley, Martin J. K., Cooke, Jennifer C., Unger, Evan C., Monaghan, Mark J., Cosgrove, David O.

Get full text

Improved detection of hepatic metastases with pulse-inversion US during the liver-specific phase of SHU 508A: multicenter study by Albrecht, Thomas, Blomley, Martin J K, Burns, Peter N, Wilson, Stephanie, Harvey, Christopher J, Leen, Edward, Claudon, Michel, Calliada, Fabrizio, Correas, Jean-Michel, LaFortune, Michel, Campani, Rodolfo, Hoffmann, Christian W, Cosgrove, David O, LeFevre, Frederic

“…To compare conventional B-mode ultrasonography (US) alone with the combination of conventional B-mode US and contrast material-enhanced (SHU 508A) late-phase…”
Get more information

Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C by Lim, A K P, Taylor-Robinson, S D, Patel, N, Eckersley, R J, Goldin, R D, Hamilton, G, Foster, G R, Thomas, H C, Cosgrove, D O, Blomley, M J K

“…Background and aims: A reliable non-invasive assessment of the severity of diffuse liver disease is much needed. We investigated the utility of hepatic vein…”
Get full text

Evidence for spleen-specific uptake of a microbubble contrast agent: a quantitative study in healthy volunteers by Lim, Adrian K P, Patel, Nayna, Eckersley, Robert J, Taylor-Robinson, Simon D, Cosgrove, David O, Blomley, Martin J K

“…To evaluate the pharmacokinetics of the microbubble contrast agent BR1. Twenty healthy volunteers were injected via arm vein with a 1.2-mL bolus of BR1…”
Get more information

Improved characterization of liver lesions with liver-phase uptake of liver-specific microbubbles: prospective multicenter study by Bryant, Thomas H, Blomley, Martin J, Albrecht, Thomas, Sidhu, Paul S, Leen, Edward L S, Basilico, Raffaella, Pilcher, James M, Bushby, Lucy H, Hoffmann, Christian W, Harvey, Christopher J, Lynch, Madeleine, MacQuarrie, John, Paul, Dennis, Cosgrove, David O

“…To evaluate in a prospective multicenter study whether conventional ultrasonographic (US) characterization of liver lesions can be improved by imaging during…”
Get more information

Liver microbubble transit time compared with histology and Child-Pugh score in diffuse liver disease: a cross sectional study by Blomley, M J K, Lim, A K P, Harvey, C J, Patel, N, Eckersley, R J, Basilico, R, Heckemann, R, Urbank, A, Cosgrove, D O, Taylor-Robinson, S D

“…Background: A previous pilot study showed that early arrival time of a microbubble in a hepatic vein is a sensitive indicator of cirrhosis. Aim: To see if this…”
Get full text

Hepatic vein transit time of SonoVue: a comparative study with Levovist by Lim, Adrian K P, Patel, Nayna, Eckersley, Robert J, Goldin, Robert D, Thomas, Howard C, Cosgrove, David O, Taylor-Robinson, Simon D, Blomley, Martin J K

“…To prospectively compare transit times of Levovist and SonoVue in healthy volunteers and patients with biopsy-proved hepatitis C-related liver disease…”
Get more information

Can Doppler Sonography Grade the Severity of Hepatitis C-Related Liver Disease? by Lim, Adrian K. P, Patel, Nayna, Eckersley, Robert J, Kuo, Yu-Ting, Goldin, Robert D, Thomas, Howard C, Cosgrove, David O, Taylor-Robinson, Simon D, Blomley, Martin J. K

“…Many authors have claimed that Doppler sonography indexes are of value in grading and assessing diffuse liver disease. However, there is much controversy…”
Get full text

Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent by Albrecht, Thomas, Blomley, Martin JK, Cosgrove, David O, Taylor-Robinson, Simon D, Jayaram, Vijay, Eckersley, Robert, Urbank, Albrecht, Butler-Barnes, Jenny, Patel, Nayna

“…Hepatic cirrhosis is accompanied by several haemodynamic changes including arterialisation of the liver, intrahepatic shunts, pulmonary arteriovenous shunts,…”
Get full text

Improved imaging of liver metastases with stimulated acoustic emission in the late phase of enhancement with the US contrast agent SH U 508A: early experience by Blomley, M J, Albrecht, T, Cosgrove, D O, Patel, N, Jayaram, V, Butler-Barnes, J, Eckersley, R J, Bauer, A, Schlief, R

“…To see whether stimulated acoustic emission (SAE) in the liver parenchyma in the late phase of enhancement with SH U 508A increases the conspicuity of occult…”
Get more information

Developments in ultrasound contrast media by Harvey, C J, Blomley, M J, Eckersley, R J, Cosgrove, D O

“…Ultrasound microbubble contrast agents are effective and safe echo enhancers. An ingenious array of methods are employed to achieve stability and provide a…”
Get full text

Pulse-inversion mode imaging of liver specific microbubbles: improved detection of subcentimetre metastases by Harvey, Christopher J, Blomley, Martin JK, Eckersley, Robert J, Heckemann, Rolf A, Butler-Barnes, Jenny, Cosgrove, David O

“…Pulse-inversion mode (a new ultrasound mode) can be used to image the late liver-specific parenchymal phase of the microbubble contrast-agent Levovist…”
Get full text

Optimisation of ultrasound-mediated gene transfer (sonoporation) in skeletal muscle cells by Liang, Hai-Dong, Lu, Qi Long, Xue, Shao-An, Halliwell, Michael, Kodama, Tetsuya, Cosgrove, David O, Stauss, Hans J, Partridge, Terence A, Blomley, Martin J K

“…Ultrasound (US) is a promising tool for facilitating direct gene transfer to skeletal muscle, but no systematic optimisation study has been performed. We…”
Get more information

Angiogenesis imaging in the management of prostate cancer by Padhani, Anwar R, Harvey, Christopher J, Cosgrove, David O

“…Angiogenesis is an integral part of benign prostatic hyperplasia, is associated with prostatic intraepithelial neoplasia and is a key factor in the growth and…”
Get full text

Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial by Kedar, R P, Bourne, T H, Powles, T J, Collins, W P, Ashley, S E, Cosgrove, D O, Campbell, S

“…Randomised, double-blind controlled trials have been started to determine whether tamoxifen can prevent or delay development of breast cancer in healthy women…”
Get more information

Diagnostic efficacy of SonoVue®, a second generation contrast agent, in the assessment of extracranial carotid or peripheral arteries using colour and spectral Doppler ultrasound : a multicentre study by SIDHU, P. S, ALLAN, P. L, LLULL, J.-B, PEZZOLI, C, SPINAZZI, A, CATTIN, F, COSGROVE, D. O, DAVIES, A. H, DO, D. D, KARAKAGIL, S, LANGHOLZ, J, LEGEMATE, D. A, MARTEGANI, A

“…The purpose of this study was to demonstrate the improvement in diagnostic quality and diagnostic accuracy of SonoVue microbubble contrast-enhanced ultrasound…”
Get full text

Prolongation and optimization of Doppler enhancement with a microbubble US contrast agent by using continuous infusion: preliminary experience by Albrecht, T, Urbank, A, Mahler, M, Bauer, A, Doré, C J, Blomley, M J, Cosgrove, D O, Schlief, R

“…To investigate whether continuous infusion of an echo-enhancing contrast agent for up to 15 minutes can provide uniform and prolonged enhancement. Six…”
Get more information

Hepatic vein transit times of a microbubble agent in assessing response to antiviral treatment in patients with chronic hepatitis C by Lim, A. K. P., Patel, N., Eckersley, R. J., Cobbold, J. F. L., Crossey, M. M. E., Cosgrove, D. O., Goldin, R. D., Thomas, H. C., Taylor-Robinson, S. D.

“…Microbubble measurement of hepatic vein transit times (HVTT) may have the potential to assess severity of hepatitis C virus (HCV)‐related liver disease, where…”
Get full text

Ovarian cancer detected non‐invasively by contrast‐enhanced power Doppler ultrasound by D'Arcy, T.J., Jayaram, V., Lynch, M., Soutter, W.P., Cosgrove, D.O., Harvey, C.J., Patel, N.

“…Overall, about one‐third of women operated upon because of suspected ovarian cancer turn out to have benign disease. This proportion will be even higher when…”
Get full text